DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAGP

Skin signs of systemic disease

Essential points for quick revision.

!
Escalate

Escalate immediately for non-blanching purpura with systemic illness, painful retiform skin with organ dysfunction, extensive blistering or detachment, suspected adrenal crisis, severe vasculitis, or signs of infective endocarditis with sepsis.

Synopsis

Recognise cutaneous clues to internal disease, separate common benign findings from time-critical syndromes, and investigate the whole clinical pattern rather than a skin sign in isolation.

  • A skin sign is a clue, not a diagnosis: integrate onset, symptoms, medicines, physiology, mucosae, nails, nodes and organ-specific findings.
  • Non-blanching petechiae or purpura in an unwell patient requires urgent assessment for infection, thrombocytopenia, coagulopathy and vasculitis.
  • Generalised pigmentation involving creases, scars or oral mucosa with weakness, weight loss and postural dizziness supports primary adrenal insufficiency.

Key red flags

Fever, hypotension, altered mental state, breathlessness, rapidly evolving purpura, mucosal injury, unexplained weight loss or acute kidney findings make a systemic skin sign urgent.

Purpura with illness

Rapidly evolving non-blanching lesions plus fever, hypotension or altered consciousness can indicate invasive infection or severe haematological disease.

Investigation priorities

01
ABCDE assessment and observationsFirst step

Identify sepsis, shock, respiratory failure or adrenal crisis before diagnostic refinement.

Management branches

Planned assessmentUse systemic dermatological examination systematically

The patient is stable and the result will alter diagnosis, referral or follow-up.

  1. Define the question for Skin signs of systemic disease, explain the process and obtain valid consent before exposing, touching, photographing or sampling skin.
  2. Choose representative anatomy, optimise lighting or specimen technique, and document site, morphology, symptoms and relevant previous treatment. Apply that step specifically within the skin signs of systemic disease assessment and its recorded clinical context.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom